242 related articles for article (PubMed ID: 8389918)
1. In vivo infection of sheep by bovine leukemia virus mutants.
Willems L; Kettmann R; Dequiedt F; Portetelle D; Vonèche V; Cornil I; Kerkhofs P; Burny A; Mammerickx M
J Virol; 1993 Jul; 67(7):4078-85. PubMed ID: 8389918
[TBL] [Abstract][Full Text] [Related]
2. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
3. In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene.
Van Den Broeke A; Bagnis C; Ciesiolka M; Cleuter Y; Gelderblom H; Kerkhofs P; Griebel P; Mannoni P; Burny A
J Virol; 1999 Feb; 73(2):1054-65. PubMed ID: 9882306
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames.
Willems L; Kerkhofs P; Dequiedt F; Portetelle D; Mammerickx M; Burny A; Kettmann R
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11532-6. PubMed ID: 7972096
[TBL] [Abstract][Full Text] [Related]
5. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
[TBL] [Abstract][Full Text] [Related]
6. Pathogenicity of molecularly cloned bovine leukemia virus.
Rovnak J; Boyd AL; Casey JW; Gonda MA; Jensen WA; Cockerell GL
J Virol; 1993 Dec; 67(12):7096-105. PubMed ID: 8230433
[TBL] [Abstract][Full Text] [Related]
7. Conservative mutations in the immunosuppressive region of the bovine leukemia virus transmembrane protein affect fusion but not infectivity in vivo.
Gatot JS; Callebaut I; Mornon JP; Portetelle D; Burny A; Kerkhofs P; Kettmann R; Willems L
J Biol Chem; 1998 May; 273(21):12870-80. PubMed ID: 9582317
[TBL] [Abstract][Full Text] [Related]
8. In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex.
Boris-Lawrie K; Altanerova V; Altaner C; Kucerova L; Temin HM
J Virol; 1997 Feb; 71(2):1514-20. PubMed ID: 8995677
[TBL] [Abstract][Full Text] [Related]
9. Lack of LTR and ENV genetic variation during bovine leukemia virus-induced leukemogenesis.
Willems L; Kerkhofs P; Burny A; Mammerickx M; Kettmann R
Virology; 1995 Jan; 206(1):769-72. PubMed ID: 7831840
[TBL] [Abstract][Full Text] [Related]
10. Discordance between bovine leukemia virus tax immortalization in vitro and oncogenicity in vivo.
Twizere JC; Kerkhofs P; Burny A; Portetelle D; Kettmann R; Willems L
J Virol; 2000 Nov; 74(21):9895-902. PubMed ID: 11024116
[TBL] [Abstract][Full Text] [Related]
11. Role of the proline-rich motif of bovine leukemia virus transmembrane protein gp30 in viral load and pathogenicity in sheep.
Reichert M; Winnicka A; Willems L; Kettmann R; Cantor GH
J Virol; 2001 Sep; 75(17):8082-9. PubMed ID: 11483753
[TBL] [Abstract][Full Text] [Related]
12. In vivo transcription of the bovine leukemia virus tax/rex region in normal and neoplastic lymphocytes of cattle and sheep.
Jensen WA; Rovnak J; Cockerell GL
J Virol; 1991 May; 65(5):2484-90. PubMed ID: 1850025
[TBL] [Abstract][Full Text] [Related]
13. A nucleotide deletion causing a translational stop in the protease reading frame of bovine leukaemia virus (BLV) results in modified protein expression and loss of infectivity.
Blankenstein P; Bondzio A; Fechner H; Beier D; Marquardt O; Looman AC; Ebner D
J Vet Med B Infect Dis Vet Public Health; 2000 Jun; 47(5):361-71. PubMed ID: 10900827
[TBL] [Abstract][Full Text] [Related]
14. In vivo transfection of bovine leukemia provirus into sheep.
Willems L; Portetelle D; Kerkhofs P; Chen G; Burny A; Mammerickx M; Kettmann R
Virology; 1992 Aug; 189(2):775-7. PubMed ID: 1322602
[TBL] [Abstract][Full Text] [Related]
15. Reduced proviral loads during primo-infection of sheep by Bovine Leukemia virus attenuated mutants.
Debacq C; Sanchez Alcaraz MT; Mortreux F; Kerkhofs P; Kettmann R; Willems L
Retrovirology; 2004 Oct; 1():31. PubMed ID: 15462678
[TBL] [Abstract][Full Text] [Related]
16. Characterization of novel Bovine Leukemia Virus (BLV) antisense transcripts by deep sequencing reveals constitutive expression in tumors and transcriptional interaction with viral microRNAs.
Durkin K; Rosewick N; Artesi M; Hahaut V; Griebel P; Arsic N; Burny A; Georges M; Van den Broeke A
Retrovirology; 2016 May; 13(1):33. PubMed ID: 27141823
[TBL] [Abstract][Full Text] [Related]
17. Genetically simpler bovine leukemia virus derivatives can replicate independently of Tax and Rex.
Boris-Lawrie K; Temin HM
J Virol; 1995 Mar; 69(3):1920-4. PubMed ID: 7853535
[TBL] [Abstract][Full Text] [Related]
18. Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model.
Kucerova L; Altanerova V; Altaner C; Boris-Lawrie K
J Virol; 1999 Oct; 73(10):8160-6. PubMed ID: 10482566
[TBL] [Abstract][Full Text] [Related]
19. The YXXL sequences of a transmembrane protein of bovine leukemia virus are required for viral entry and incorporation of viral envelope protein into virions.
Inabe K; Nishizawa M; Tajima S; Ikuta K; Aida Y
J Virol; 1999 Feb; 73(2):1293-301. PubMed ID: 9882334
[TBL] [Abstract][Full Text] [Related]
20. Use of the bovine leukaemia virus LTR U3 promoter for expressing antisense antiviral RNAs and competitive inhibition of viral infection in cell culture.
Shayakhmetov D; Kovalenko D; Yurov G; Borisenko A; Tikchonenko T
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1941-8. PubMed ID: 9266992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
